close

Вход

Забыли?

вход по аккаунту

код для вставкиСкачать
Time to Primary Outcome
# at Risk
T
8,542
R
8,576
Yr 1
8,177
8,214
Yr 2
7,778
7,832
Yr 3
7,420
7,472
Yr 4
7,051
7,093
Yr 4.5
4,575
4,562
Cumulative Hazard Rates
0.25
0.20
0.15
Telmisartan
Ramipril
0.10
0.05
1,412 (16.5%) vs. 1,423 (16.7%); RR 1.01 (0.94-1.09)
0.0
0
1
2
3
4
Years of Follow-up
Adapted from The ONTARGET Investigators. N Engl J Med 2008;358:1547-59.
Adherence Rates of Antihypertensive Medication
During Six to 24 Months in Saskatchewan
80
70
* **
**
Percentage (%)
60
50
40
30
20
10
0
*P=0.001 vs. each of the other classes; **P=0.030 vs. DIUR, P=0.002 vs. others
Adapted from Chaput AJ. Saskatchewan Health Database
6 mos
12 mos
18 mos
24 mos
1/--страниц
Пожаловаться на содержимое документа